SINCALIDE
Active substance: sincalide
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · SINCALIDE 5 ug/5mL
United StatesActive
Marketing holder: Fresenius Kabi USA, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SINCALIDE · 5 ug/5mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12092-2fff-7583-bd1e-8a3cc7ebe08b,01a12095-1568-7cd1-aed1-f015d458da72,01a12096-bc99-77cf-add1-9db0a191c253,01a12099-76c5-7774-95bd-79f393dbbd33;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 63323-579
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 63323-579 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63323-579 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63323-579 · Verified 2026-10-09 · open in source